The schedule can be downloaded at the event's website.
Those of you eager to learn about the future of EPA and DHA omega-3 markets have likely already registered for GOED Exchange 2012, taking place in Boston in June.
Now, the Global Organization for EPA and DHA Omega-3s (GOED; Salt Lake City) has released the full lineup of speakers and session for the event.
Some of the more interesting topics include a focus on China and its evolving omega-3 market, a look at market research on omega-3 volumes and product launches around the world, and a hands-on workshop to spark omega-3 innovation for your company.
GOED Exchange 2012 will play host to scientists, marketing experts, industry historians, international NGOs, and more. Check out the full lineup at the link above.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.